These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35430799)

  • 41. Clinical features and prognosis in hepatectomy for colorectal cancer with centrally located liver metastasis.
    Kuo IM; Huang SF; Chiang JM; Yeh CY; Chan KM; Chen JS; Yu MC
    World J Surg Oncol; 2015 Mar; 13():92. PubMed ID: 25889950
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prospective evaluation of two-stage hepatectomy combined with selective portal vein embolisation and systemic chemotherapy for patients with unresectable bilobar colorectal liver metastases.
    Pamecha V; Nedjat-Shokouhi B; Gurusamy K; Glantzounis GK; Sharma D; Davidson BR
    Dig Surg; 2008; 25(5):387-93. PubMed ID: 19033722
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A meta-analysis exploring the role of PET and PET-CT in the management of potentially resectable colorectal cancer liver metastases.
    Daza JF; Solis NM; Parpia S; Gallinger S; Moulton CA; Belley-Cote EP; Levine MN; Serrano PE
    Eur J Surg Oncol; 2019 Aug; 45(8):1341-1348. PubMed ID: 30928334
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of outcomes and treatment safety of patients with metastatic colorectal cancer to the liver with estimation of prognostic factors.
    Zeman M; Maciejewski A; Półtorak S; Kryj M
    Pol Przegl Chir; 2013 Jun; 85(6):333-9. PubMed ID: 23828415
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Parenchymal-sparing hepatectomies (PSH) for bilobar colorectal liver metastases are associated with a lower morbidity and similar oncological results: a propensity score matching analysis.
    Memeo R; de Blasi V; Adam R; Goéré D; Azoulay D; Ayav A; Gregoire E; Kianmanesh R; Navarro F; Sa Cunha A; Pessaux P;
    HPB (Oxford); 2016 Sep; 18(9):781-90. PubMed ID: 27593596
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Parenchyma sparing or Anatomical Resections for Colorectal Liver Metastases?].
    Ghamarnejad O; Stavrou GA
    Zentralbl Chir; 2022 Aug; 147(4):381-388. PubMed ID: 35764304
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Surgical treatment of liver metastases from colorectal cancer].
    Popescu I; Ionescu M; Alexandrescu S; Ciurea S; Hrehoreţ D; Sârbu-Boeţi P; Boroş M; Croitoru A; Anghel R
    Chirurgia (Bucur); 2006; 101(1):13-24. PubMed ID: 16623372
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comprehensive Intrametastatic Immune Quantification and Major Impact of Immunoscore on Survival.
    Mlecnik B; Van den Eynde M; Bindea G; Church SE; Vasaturo A; Fredriksen T; Lafontaine L; Haicheur N; Marliot F; Debetancourt D; Pairet G; Jouret-Mourin A; Gigot JF; Hubert C; Danse E; Dragean C; Carrasco J; Humblet Y; Valge-Archer V; Berger A; Pagès F; Machiels JP; Galon J
    J Natl Cancer Inst; 2018 Jan; 110(1):. PubMed ID: 28922789
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of increased resection rates and a liver parenchyma sparing strategy on long-term survival after surgery for colorectal liver metastases. A population-based study.
    Even Storli P; Johnsen G; Juel IS; Grønbech JE; Bringeland EA
    Scand J Gastroenterol; 2019 Jul; 54(7):890-898. PubMed ID: 31318299
    [No Abstract]   [Full Text] [Related]  

  • 50. Two-stage resection for bilobar colorectal liver metastases: R0 resection is the key.
    Tsim N; Healey AJ; Frampton AE; Habib NA; Bansi DS; Wasan H; Cleator SJ; Stebbing J; Lowdell CP; Jackson JE; Tait P; Jiao LR
    Ann Surg Oncol; 2011 Jul; 18(7):1939-46. PubMed ID: 21298352
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Parenchymal-sparing hepatectomy for colorectal liver metastases reduces postoperative morbidity while maintaining equivalent oncologic outcomes compared to non-parenchymal-sparing resection.
    Andreou A; Gloor S; Inglin J; Di Pietro Martinelli C; Banz V; Lachenmayer A; Kim-Fuchs C; Candinas D; Beldi G
    Surg Oncol; 2021 Sep; 38():101631. PubMed ID: 34298267
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatic vein-sparing hepatectomy for multiple colorectal liver metastases at the caval confluence.
    Torzilli G; Procopio F; Cimino M; Donadon M; Fabbro DD; Costa G; Garcia-Etienne CA
    Ann Surg Oncol; 2015 May; 22(5):1576. PubMed ID: 25352266
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis].
    Bao Q; Wang K; Wang HW; Jin KM; Xing BC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):976-983. PubMed ID: 33053993
    [No Abstract]   [Full Text] [Related]  

  • 54. [Comparison of follow-up treatment regimens for colorectal cancer liver metastases without objective response to neoadjuvant chemotherapy: direct surgery or surgery after second-line chemotherapy].
    Lyu XY; Bi XY; Zhao H; Chen QC; Luo ZW; Zhang BL; Zhang XS; Cai JQ
    Zhonghua Wai Ke Za Zhi; 2022 May; 60(5):454-460. PubMed ID: 35359087
    [No Abstract]   [Full Text] [Related]  

  • 55. Simultaneous Parenchyma-Preserving Liver Resection, Cytoreductive Surgery and Intraperitoneal Chemotherapy for Stage IV Colorectal Cancer.
    Abreu de Carvalho LF; Scuderi V; Maes H; Cupo P; Geerts B; Van Bockstal M; Gremonprez F; Willaert W; Pattyn P; Troisi R; Ceelen W
    Acta Chir Belg; 2015; 115(4):261-7. PubMed ID: 26324026
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Survival after associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) for advanced colorectal liver metastases: A case-matched comparison with palliative systemic therapy.
    Olthof PB; Huiskens J; Wicherts DA; Huespe PE; Ardiles V; Robles-Campos R; Adam R; Linecker M; Clavien PA; Koopman M; Verhoef C; Punt CJ; van Gulik TM; de Santibanes E
    Surgery; 2017 Apr; 161(4):909-919. PubMed ID: 28038862
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ["Liver fist approach" in the management of synchronous liver metastases from colorectal cancer: Preliminary non-randomized study results].
    Pudil J; Batko S; Menclová K; Bláha M; Ryska M
    Rozhl Chir; 2015 Dec; 94(12):522-5. PubMed ID: 26767903
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oncological outcomes of laparoscopic surgery of liver metastases: a single-centre experience.
    Cipriani F; Rawashdeh M; Ahmed M; Armstrong T; Pearce NW; Abu Hilal M
    Updates Surg; 2015 Jun; 67(2):185-91. PubMed ID: 26109140
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The extent of resection influences outcome following hepatectomy for colorectal liver metastases.
    Stewart GD; O'Súilleabháin CB; Madhavan KK; Wigmore SJ; Parks RW; Garden OJ
    Eur J Surg Oncol; 2004 May; 30(4):370-6. PubMed ID: 15063889
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Parenchyma-sparing hepatectomy (PSH) versus non-PSH for bilobar liver metastases of colorectal cancer.
    Spelt L; Ansari D; Swanling M; Holka P; Andersson R
    Ann Gastroenterol; 2018; 31(1):115-120. PubMed ID: 29333076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.